| MeSH term | MeSH ID | Detail |
|---|---|---|
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | D054438 | 1 associated lipids |
| POEMS Syndrome | D016878 | 1 associated lipids |
| Fibroma, Ossifying | D018214 | 1 associated lipids |
| Dental Pulp Calcification | D003784 | 2 associated lipids |
| Hypertension, Pregnancy-Induced | D046110 | 2 associated lipids |
| Pasteurellaceae Infections | D016871 | 2 associated lipids |
| Bone Cysts, Aneurysmal | D017824 | 2 associated lipids |
| Bone Diseases, Developmental | D001848 | 2 associated lipids |
| Actinomycosis | D000196 | 2 associated lipids |
| Fractures, Stress | D015775 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Theoleyre S et al. | The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. | 2004 | Cytokine Growth Factor Rev. | pmid:15561602 |
| Walsh MC and Choi Y | Biology of the TRANCE axis. | 2003 Jun-Aug | Cytokine Growth Factor Rev. | pmid:12787563 |
| Zauli G and Secchiero P | The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. | 2006 | Cytokine Growth Factor Rev. | pmid:16750931 |
| Zhang Y et al. | Osteogenic properties of hydrophilic and hydrophobic titanium surfaces evaluated with osteoblast-like cells (MG63) in coculture with human umbilical vein endothelial cells (HUVEC). | 2010 | Dent Mater | pmid:20728208 |
| Rausch-fan X et al. | Differentiation and cytokine synthesis of human alveolar osteoblasts compared to osteoblast-like cells (MG63) in response to titanium surfaces. | 2008 | Dent Mater | pmid:17467048 |
| Zhan X et al. | Storage media enhance osteoclastogenic potential of human periodontal ligament cells via RANKL-independent signaling. | 2013 | Dent Traumatol | pmid:22487464 |
| Panzarini SR et al. | Histological and immunohistochemical analyses of the chronology of healing process after immediate tooth replantation in incisor rat teeth. | 2013 | Dent Traumatol | pmid:22413942 |
| Saito CT et al. | Effect of low-level laser therapy on the healing process after tooth replantation: a histomorphometrical and immunohistochemical analysis. | 2011 | Dent Traumatol | pmid:21244626 |
| Fernández-González FJ et al. | Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. | 2015 | Dental Press J Orthod | pmid:26560822 |
| Matsumoto K et al. | Cytokine profile in synovial fluid from patients with internal derangement of the temporomandibular joint: a preliminary study. | 2006 | Dentomaxillofac Radiol | pmid:17082335 |
| Gori F et al. | Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development. | 2006 | Dev. Biol. | pmid:16730692 |
| Kieslinger M et al. | EBF2 regulates osteoblast-dependent differentiation of osteoclasts. | 2005 | Dev. Cell | pmid:16326388 |
| Glass DA et al. | Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. | 2005 | Dev. Cell | pmid:15866165 |
| Durán A et al. | The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. | 2004 | Dev. Cell | pmid:14960283 |
| Sutton KM et al. | The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. | 2015 | Dev. Comp. Immunol. | pmid:25796577 |
| Kamiya N et al. | BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. | 2008 | Development | pmid:18927151 |
| Li J et al. | [Effect of raloxifene and estradiol on the biological function and osteoprotegerin expression of osteoblasts in vitro]. | 2005 | Di Yi Jun Yi Da Xue Xue Bao | pmid:16027068 |
| Guzel S et al. | Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. | 2013 | Diab Vasc Dis Res | pmid:22496403 |
| Xiang GD et al. | Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes. | 2009 | Diabet. Med. | pmid:19388970 |
| Korzon-Burakowska A et al. | Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. | 2012 | Diabet. Med. | pmid:21913967 |
| Nybo M et al. | Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients. | 2010 | Diabet. Med. | pmid:20536491 |
| Ndip A et al. | The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. | 2011 | Diabetes | pmid:21659498 |
| Xiang GD et al. | The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes. | 2006 | Diabetes | pmid:16804084 |
| Mahamed DA et al. | G(-) anaerobes-reactive CD4+ T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. | 2005 | Diabetes | pmid:15855336 |
| Sultan A et al. | Osteoprotegerin, thiazolidinediones treatment, and silent myocardial ischemia in type 2 diabetic patients. | 2008 | Diabetes Care | pmid:18083791 |
| Avignon A et al. | Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients. | 2007 | Diabetes Care | pmid:17712025 |
| Nellemann B et al. | Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria. | 2007 | Diabetes Care | pmid:17804683 |
| Gordin D et al. | Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. | 2013 | Diabetes Care | pmid:23801795 |
| Shin JY et al. | Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes. | 2006 | Diabetes Care | pmid:16801598 |
| Madarász E et al. | Osteoprotegerin levels in women with prior gestational diabetes mellitus. | 2009 | Diabetes Care | pmid:19114622 |
| Pitocco D et al. | Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study. | 2009 | Diabetes Care | pmid:19502537 |
| Reinhard H et al. | Osteoprotegerin and mortality in type 2 diabetic patients. | 2010 | Diabetes Care | pmid:20929997 |
| Avignon A et al. | Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. | 2005 | Diabetes Care | pmid:16123486 |
| Alexopoulou O et al. | Bone density and markers of bone remodeling in type 1 male diabetic patients. | 2006 | Diabetes Metab. | pmid:17110900 |
| Molines L et al. | Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. | 2010 | Diabetes Metab. | pmid:20570543 |
| O'Sullivan EP et al. | Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes. | 2010 | Diabetes Metab. Res. Rev. | pmid:20809534 |
| Shirakawa J and Kulkarni RN | Novel factors modulating human β-cell proliferation. | 2016 | Diabetes Obes Metab | pmid:27615134 |
| Singh DK et al. | Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. | 2012 | Diabetes Res. Clin. Pract. | pmid:22386825 |
| Xiang GD et al. | Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients. | 2007 | Diabetes Res. Clin. Pract. | pmid:17023086 |
| Akinci B et al. | Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes. | 2008 | Diabetes Res. Clin. Pract. | pmid:18722030 |
| Ishiyama M et al. | Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients. | 2009 | Diabetes Res. Clin. Pract. | pmid:19497632 |
| Lee JE et al. | Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population. | 2010 | Diabetes Res. Clin. Pract. | pmid:20092902 |
| Suzuki K et al. | Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. | 2005 | Diabetes Res. Clin. Pract. | pmid:15860239 |
| Loureiro MB et al. | Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. | 2014 | Diabetes Res. Clin. Pract. | pmid:24529565 |
| Akinci B et al. | Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. | 2011 | Diabetes Res. Clin. Pract. | pmid:20970873 |
| Ugur-Altun B et al. | The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity. | 2005 | Diabetes Res. Clin. Pract. | pmid:15936463 |
| Jorsal A et al. | Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy. | 2008 | Diabetologia | pmid:18719882 |
| Olesen P et al. | Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha. | 2005 | Diabetologia | pmid:15700136 |
| Jeffcoate W | Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? | 2004 | Diabetologia | pmid:15322748 |
| Schrader J et al. | Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death. | 2007 | Diabetologia | pmid:17443309 |
| Kim S et al. | Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis. | 2012 | Diagn. Microbiol. Infect. Dis. | pmid:22647538 |
| Nahidi L et al. | Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. | 2013 | Dig. Dis. Sci. | pmid:24048682 |
| Brambila-Tapia AJ et al. | MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. | 2012 | Dis. Markers | pmid:22377704 |
| Kurz K et al. | Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. | 2015 | Dis. Markers | pmid:26576067 |
| Hassan SH et al. | Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. | 2015 | Dis. Markers | pmid:25814780 |
| Guo L et al. | Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. | 2014 | DNA Cell Biol. | pmid:24283361 |
| Qiao B et al. | Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. | 2015 | Drug Des Devel Ther | pmid:25733814 |
| Bateman TA and Countryman S | Osteoprotegerin and bone loss associated with spaceflight. | 2002 | Drug Discov. Today | pmid:11965392 |
| Heymann D et al. | Osteolytic bone diseases: physiological analogues of bone resorption effectors as alternative therapeutic tools. | 2005 | Drug Discov. Today | pmid:15708742 |
| Hofbauer LC and Kühne CA | Cytokine inhibition: a new therapeutic avenue for skeletal diseases. | 2002 | Drug Discov. Today | pmid:11854049 |
| Hamdy NA | Denosumab: RANKL inhibition in the management of bone loss. | 2008 | Drugs Today | pmid:18301800 |
| Schlieper G et al. | [Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?]. | 2007 | Dtsch. Med. Wochenschr. | pmid:17726653 |
| Hofbauer LC and Heufelder AE | [Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases]. | 2001 | Dtsch. Med. Wochenschr. | pmid:11233883 |
| Widschwendter M et al. | Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629528 |
| Rachner TD and Rauner M | RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629502 |
| Maser RE et al. | Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes. | 2015 | Endocr Pract | pmid:25100392 |
| Elabd SK et al. | Possible neuroendocrine role for oxytocin in bone remodeling. | 2007 | Endocr Regul | pmid:18257653 |
| Ohwada R et al. | The relationship between serum levels of estradiol and osteoprotegerin in patients with anorexia nervosa. | 2007 | Endocr. J. | pmid:17998762 |
| Yu F et al. | Association between osteoprotegerin genetic variants and osteoporosis in Chinese postmenopausal women. | 2013 | Endocr. J. | pmid:24067544 |
| Fietta P and Manganelli P | A case of hepatitis C-associated osteosclerosis in an elderly man. Comment on the article by Tanaka et al. | 2007 | Endocr. J. | pmid:17135709 |
| Rhee EJ et al. | The relationship between Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women. | 2010 | Endocr. J. | pmid:20431232 |
| Okada Y et al. | Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption. | 2002 | Endocr. J. | pmid:12402981 |
| Martinetti A et al. | Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. | 2004 | Endocr. Relat. Cancer | pmid:15613451 |
| Jiang XY et al. | TNFRSF11B polymorphisms are associated with metabolic traits in Uyghur and Han ethnic groups. | 2014 | Endocr. Res. | pmid:23772656 |
| Kearns AE et al. | Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. | 2008 | Endocr. Rev. | pmid:18057140 |
| Nguyen KQ et al. | Bone morphogenetic proteins regulate osteoprotegerin and its ligands in human vascular smooth muscle cells. | 2007 | Endocrine | pmid:17992602 |
| Brunetti G et al. | Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. | 2012 | Endocrine | pmid:22638612 |
| Jiang XY et al. | A polymorphism near osteoprotegerin gene confer risk of obesity in Uyghurs. | 2010 | Endocrine | pmid:20960157 |
| Enjuanes A et al. | The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. | 2010 | Endocrine | pmid:20960270 |
| Yan MZ et al. | Raloxifene inhibits bone loss and improves bone strength through an Opg-independent mechanism. | 2010 | Endocrine | pmid:20963556 |
| Loncar G et al. | Relationship between RANKL and neuroendocrine activation in elderly males with heart failure. | 2010 | Endocrine | pmid:20963564 |
| Enjuanes A et al. | The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. | 2010 | Endocrine | pmid:20963568 |
| Deng YH et al. | The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. | 2013 | Endocrine | pmid:22798246 |
| Rivadeneira F | Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. | 2013 | Endocrine | pmid:23001603 |
| Reyes-GarcÃa R et al. | [Cardiovascular disease and bone metabolism]. | 2011 Aug-Sep | Endocrinol Nutr | pmid:21775224 |
| Heim M et al. | The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. | 2004 | Endocrinology | pmid:14605006 |
| Weinstein RS et al. | Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice. | 2011 | Endocrinology | pmid:21771887 |
| Cornish J et al. | Modulation of osteoclastogenesis by fatty acids. | 2008 | Endocrinology | pmid:18617622 |
| Udagawa N et al. | Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. | 2000 | Endocrinology | pmid:10965921 |
| Yasuda H et al. | Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. | 1998 | Endocrinology | pmid:9492069 |
| Yamamoto M et al. | Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. | 1998 | Endocrinology | pmid:9724059 |
| Hofbauer LC et al. | Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. | 1999 | Endocrinology | pmid:10499489 |
| Thomas RJ et al. | Breast cancer cells interact with osteoblasts to support osteoclast formation. | 1999 | Endocrinology | pmid:10499498 |
| Ming LG et al. | The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. | 2013 | Endocrinology | pmid:23389955 |
| Kuriwaka-Kido R et al. | Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess. | 2013 | Endocrinology | pmid:23397032 |
| Ferrari SL et al. | Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. | 2005 | Endocrinology | pmid:15705780 |
| Kostenuik PJ et al. | OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats. | 2001 | Endocrinology | pmid:11564687 |
| Nardelli B et al. | Osteostat/tumor necrosis factor superfamily 18 inhibits osteoclastogenesis and is selectively expressed by vascular endothelial cells. | 2006 | Endocrinology | pmid:16179414 |
| Wang FS et al. | Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats. | 2004 | Endocrinology | pmid:14962990 |
| Yoneda T et al. | Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. | 2004 | Endocrinology | pmid:14726437 |